Additionally, recent experimental and clinical studies have shown that FGF23 can be involved in systemic inflammation, hypertension, iron metabolism, and cardiovascular disease, among other comorbidities associated with CKD [7,9,13,14,15]. Here, FGF23 is linked to chronic kidney disease.